University of Texas Texas AM Investment Management Co. Has $1.91 Million Stake in The Procter & Gamble Company (NYSE:PG)

University of Texas Texas AM Investment Management Co. reduced its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 13.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,574 shares of the company’s stock after selling 1,828 shares during the period. University of Texas Texas AM Investment Management Co.’s holdings in Procter & Gamble were worth $1,909,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. HighPoint Advisor Group LLC bought a new stake in shares of Procter & Gamble in the fourth quarter valued at approximately $17,696,000. Bayesian Capital Management LP grew its holdings in shares of Procter & Gamble by 43.0% during the 4th quarter. Bayesian Capital Management LP now owns 52,840 shares of the company’s stock worth $7,743,000 after purchasing an additional 15,900 shares in the last quarter. Steele Capital Management Inc. bought a new position in shares of Procter & Gamble in the first quarter worth $204,000. Mosley Wealth Management acquired a new position in Procter & Gamble in the fourth quarter valued at about $537,000. Finally, United Advisor Group LLC bought a new stake in Procter & Gamble during the fourth quarter worth about $3,463,000. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Stock Down 0.1 %

Shares of PG opened at $173.07 on Wednesday. The company has a market capitalization of $408.47 billion, a PE ratio of 28.28, a PEG ratio of 3.76 and a beta of 0.41. The stock’s 50-day moving average price is $171.01 and its two-hundred day moving average price is $166.36. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a 12 month low of $141.45 and a 12 month high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Tuesday, July 30th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The business had revenue of $20.53 billion for the quarter, compared to analysts’ expectations of $20.69 billion. During the same period in the prior year, the business posted $1.37 earnings per share. The firm’s revenue was down .1% on a year-over-year basis. On average, analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Friday, July 19th were issued a $1.0065 dividend. The ex-dividend date was Friday, July 19th. This represents a $4.03 annualized dividend and a yield of 2.33%. Procter & Gamble’s payout ratio is 65.69%.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Dbs Bank cut shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 1st. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, August 23rd. Evercore ISI lifted their price target on Procter & Gamble from $177.00 to $183.00 and gave the company an “outperform” rating in a research note on Thursday, July 18th. Deutsche Bank Aktiengesellschaft upped their price objective on Procter & Gamble from $171.00 to $176.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. Finally, StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Nine analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus target price of $175.89.

Get Our Latest Research Report on Procter & Gamble

Insider Buying and Selling at Procter & Gamble

In other news, CFO Andre Schulten sold 13,041 shares of the business’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Jon R. Moeller sold 72,174 shares of the stock in a transaction on Friday, August 9th. The shares were sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the transaction, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at $45,002,649.58. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction on Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at $6,325,360. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 375,553 shares of company stock valued at $63,829,141. 0.17% of the stock is currently owned by insiders.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.